Abacavir Sulfate/ Lamivudine Tablets 120mg/60mg Kenia - englanti - Pharmacy and Poisons Board

abacavir sulfate/ lamivudine tablets 120mg/60mg

mylan laboratories limited mylan laboratories limited plot no.5 64l a122, - abacavir sulfate usp lamivudine usp - tablet - abacavir sulfate 120mg usp lamivudine usp 60mg - abacavir

ANTIXIETY 75 (Pregabalin capsules 75 mg) Capsule, Hard Kenia - englanti - Pharmacy and Poisons Board

antixiety 75 (pregabalin capsules 75 mg) capsule, hard

mylan laboratories limited mylan laboratories limited, plot no.564/a/22, - pregabalin - capsule, hard - pregabalin capsules 75 mg - pregabalin

Cinacalcet Mylan Euroopan unioni - englanti - EMA (European Medicines Agency)

cinacalcet mylan

mylan pharmaceuticals limited - cinacalcet hydrochloride - hyperparathyroidism, secondary; hypercalcemia - calcium homeostasis - treatment of secondary hyperparathyroidism (hpt) in patients with end-stage renal disease (esrd) on maintenance dialysis therapy.cinacalcet mylan may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate.reduction of hypercalcaemia in patients with:parathyroid carcinomaprimary hpt for whom parathyroidectomywould be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated. 

Deferasirox Mylan Euroopan unioni - englanti - EMA (European Medicines Agency)

deferasirox mylan

mylan pharmaceuticals limited - deferasirox - iron overload; beta-thalassemia - iron chelating agents - deferasirox mylan is indicated forthe treatment of chronic iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with beta thalassaemia major aged 6 years and olderthe treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:in paediatric patients with beta thalassaemia major with iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) aged 2 to 5 years,in adult and paediatric patients with beta thalassaemia major with iron overload due to infrequent blood transfusions (

HepBest Tablets 25 Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

hepbest tablets 25

mylan laboratories limited, india - tenofovir alafenamide - tablets - 25

ALLTERA 50 Granules Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

alltera 50 granules

mylan laboratories limited, india - lopinavir , ritonavir - granules - 50

MYLTEGA DT Film Coated Tablet 10 Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

myltega dt film coated tablet 10

mylan laboratories limited, india - dolutegravir sodium - film coated tablet - 10

MyDekla 60 Tablets 60 mg Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

mydekla 60 tablets 60 mg

mylan laboratories limited, india - daclatasvir dihydrochloride - tablets - 60 mg

Durart 800 Tablets 800 mg Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

durart 800 tablets 800 mg

mylan laboratories limited, india - darunavir - tablets - 800 mg

Durart 600 Tablets 600 mg Tansania - englanti - Tanzania Medicinces & Medical Devices Authority

durart 600 tablets 600 mg

mylan laboratories limited, india - darunavir - tablets - 600 mg